MEDNAX, INC. (NYSE:MD) Files An 8-K Results of Operations and Financial Condition

Item2.02

On February7, 2017, MEDNAX, Inc., a Florida corporation (the
Company), issued a press release announcing the results of its
operations for the three months and 12 months ended December31,
2016 (the Fourth Quarter Release).A copy of the Fourth Quarter
Release is attached hereto as Exhibit 99.1 and is hereby
incorporated in this Current Report by reference.The information
contained in this Item2.02, including Exhibit 99.1, shall not be
deemed filed with the Securities and Exchange Commission nor
incorporated by reference in any registration statement or other
document filed by the Company under the Securities Act of 1933,
as amended, except as shall be expressly set forth by specific
reference in such filing.

About MEDNAX, INC. (NYSE:MD)

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.

MEDNAX, INC. (NYSE:MD) Recent Trading Information

MEDNAX, INC. (NYSE:MD) closed its last trading session up +0.19 at 68.92 with 649,191 shares trading hands.